Vunakizumab (Anti-CTLA-8 / IL-17a)
Product Specifications
CAS Number
1792181-33-9
SKU
C00621-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Vunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGκ monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470029-100 1x 100 µL
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880218-500 1x 500 µL
CD100 (Semaphorin-4D) (A8), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681135-500 1x 500 µL
P21 / WAF1 (CIP1/823 + DCS-60.2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042875-500 1x 500 µL
CD44 / HCAM Std. (HCAM/2875R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 